THE INTERNATIONAL PATENT APPLICATION FOR ELDERCRAFT® HAS BEEN PUBLISHED
Marking a significant milestone: on June 15th, 2023 the international patent application for ElderCraft® has been published: “ELDERBERRY EXTRACT FOR USE IN A METHOD OF PREVENTING OR TREATING SARS-CoV-2 INFECTION”
The laboratory headed by Prof. Schubert Institute of Virology, Friedrich-Alexander University Erlangen-Nürnberg studied the effect of ElderCraft®, an extract made by IPRONA from Sambucus nigra, L. black elderberries (variety Haschberg) on the replication of SARS-CoV-2 coronavirus that causes COVID-19. The study revealed that ElderCraft® inhibits at the replication of the virus in vitro.
Encouraged by these findings, IPRONA filed an international patent describing ElderCraft® for use in the prevention and treatment of COVID-19.
Prof. Schubert points out that their recent research findings indicate the extract exhibits potent anti-SARS-CoV-2 activity. The remarkable efficacy of this extract is not confined to the Wuhan type of the virus; it extends equally to variants of concern Alpha, Beta, Gamma, Delta, and Omicron.
ElderCraft® is a branded, high-quality natural ingredient derived from the European Black Elderberry Extract, Sambucus nigra. This premium product is utilized worldwide as an ingredient in a variety of food supplements designed to boost immunity.
The extract is made by an entirely mechanical, solvent-free ultra-filtration process to enrich an active blend of polyphenols, anthocyanins, polysaccharides and berry micronutrients from “Haschberg” elderberries grown exclusively for Iprona in southeast Austria.